Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Field Trip Health Ltd. (FTRP.CN)

Field Trip Health Ltd. (FTRP.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 210,823
  • Shares Outstanding, K 42,445
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade FTRP.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings -0.22 on 12/31/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.760 +16.60%
on 05/31/21
7.000 -20.71%
on 05/13/21
-0.200 (-3.48%)
since 05/04/21
3-Month
4.760 +16.60%
on 05/31/21
7.000 -20.71%
on 05/13/21
-0.930 (-14.35%)
since 03/04/21

Most Recent Stories

More News
The Weight Loss Tool That Could Help Nearly 1.9 Billion People

The obesity epidemic is still bursting at the seams. At the moment, 1.9 billion people are overweight, ...

CYBN : 2.14 (-0.93%)
CLXPF : 3.0200 (-1.31%)
MMEDF : 4.6900 (+33.24%)
OPTHF : 0.4800 (-1.44%)
FTRP.TO : 5.42 (-1.09%)
FTRP : 4.23 (-3.20%)
NMDBF : 0.0868 (+7.03%)
FTRP.CN : 5.550 (+1.46%)
OPTI.CN : 0.610 (-3.17%)
NEON.CN : 0.100 (-4.76%)
Field Trip Health Ltd. to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit

Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Ronan Levy, Co-Founder & Executive...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
This Key Psychedelic Could Revolutionize Depression Treatment for Millions

Mental health is on the decline all over the world. At the moment, nearly 264 million people are ...

CYBN : 2.14 (-0.93%)
CLXPF : 3.0200 (-1.31%)
MNMD : 2.38 (-2.86%)
NMED : 0.0001 (unch)
CMPS : 31.37 (-5.34%)
FTRPF : 5.7460 (-2.32%)
FTRP.CN : 5.550 (+1.46%)
MYND.CN : 0.930 (+24.00%)
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results

Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, reported its fiscal year end results for the three and twelve...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET

Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development

/PRNewswire/ -- The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising medicines can get...

OILFF : 0.1638 (-7.46%)
OILS.CN : 0.210 (-6.67%)
MNMD : 2.38 (-2.86%)
LKYSF : 0.6500 (+6.70%)
NUMI.VN : 0.840 (+9.09%)
FTRPF : 5.7460 (-2.32%)
FTRP.CN : 5.550 (+1.46%)
CRTPF : 2.3000 (+5.50%)
CRDL.TO : 5.02 (-7.04%)
Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound

Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, today announced that it has completed initial drug metabolism...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
Psilocybin Could Help Treat Nearly 264 Million with Depression

Mental health is on the decline all over the world. In fact, as you read this, nearly 264 million ...

FTRPF : 5.7460 (-2.32%)
MNMD : 2.38 (-2.86%)
CMPS : 31.37 (-5.34%)
KONEF : 1.0199 (-18.41%)
FTRP.CN : 5.550 (+1.46%)
MYND.CN : 0.930 (+24.00%)
Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market

Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has applied to list its common...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
Field Trip Health Ltd. to Commence Trading on the Toronto Stock Exchange on June 7, 2021

Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to announce that its common shares will commence...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)

Key Turning Points

3rd Resistance Point 5.737
2nd Resistance Point 5.643
1st Resistance Point 5.597
Last Price 5.550
1st Support Level 5.457
2nd Support Level 5.363
3rd Support Level 5.317

See More

52-Week High 9.880
Fibonacci 61.8% 6.965
Fibonacci 50% 6.065
Last Price 5.550
Fibonacci 38.2% 5.165
52-Week Low 2.250

See More

Business Summary

Field Trip Health Ltd is engaged in the development and delivery of psychedelic therapies. Its operating segments include Clinical Operations, Research, and Corporate. With its Field Trip Discovery, the company's research division, leading the development of the next generation of psychedelic molecules...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar